Matters of legal in nature including licensing, intellectual property, and lawsuits.
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing... Read more
Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market LEXINGTON, Mass.–(BUSINESS WIRE)–Sep. 12, 2018– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the consolidation of its licensing position and reestablishment of control of its intellectual property in the in vitro diagnostics (IVD) field. The termination... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Sep. 5, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its President and Chief Executive Officer, Patrick Decker, and Sr. Director of Investor Relations, Matthew Latino will participate in group discussions at the Morgan Stanley 6th Annual Laguna... Read more
Download as PDF August 30, 2018 Invention Opens Path for Integration of Automated ”Hands-Free” Sample Prep Workflows Utilizing Company’s Patented High-Pressure Platform Technologies SOUTH EASTON, MA / ACCESSWIRE / August 30, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (”PBI” or the ”Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA). This is Illumina’s first CNDA-cleared, next-generation sequencing (NGS) system in China. In accordance with the clearance, Illumina can now market and sell the MiSeqDx Sequencing System to hospitals and other medical institutions... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 27, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President and President, Americas Commercial Team and Applied Water SystemsKen Napolitano and Sr. Director of Investor Relations Matt Latino will participate in the Seaport Global... Read more
AUG 22, 2018 Download PDF Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its complaint, Twist informed – and provided to Agilent – the... Read more
Basel, 22 August 2018 Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Tuesday, 25 September 2018, highlighting the results... Read more
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
http://ir.takara-bio.co.jp/en/news_all/news_IR/auto_20180822499609/pdfFile.pdf Read more